EVOTEC ORD SHS's operating income is $-130M.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
EVOTEC ORD SHS (EVOTF) currently reports a operating income of $-130M as of June 2026. That compares with $-67M in the prior-year period — down 90.8% year over year. Use the charts on this page to explore EVOTEC ORD SHS's operating income history and peer comparisons.
EVOTEC ORD SHS's operating income decreased from $-67M to $-130M — a 90.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
EVOTEC ORD SHS reported $-130M in operating income as of June 2026. That compares with $-67M in the prior-year period — down 90.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current operating income of $-130M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for EVOTEC ORD SHS, and consider following EVOTF for alerts when major investors trade the stock.
EVOTEC ORD SHS is classified in the Healthcare sector. On operating income, it currently shows $-130M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EVOTF with unrelated industries.